Tudor Investment Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-84,550
| Closed | -$47.8M | – | 3786 |
|
|
2025
Q2 | $44.4M | Sell |
84,550
-41,543
| -33% | -$23.2M | 0.1% | 143 |
|
|
2025
Q1 | $80M | Buy |
126,093
+97,523
| +341% | +$67.1M | 0.27% | 34 |
|
|
2024
Q4 | $20.4M | Sell |
28,570
-9,081
| -24% | -$7.62M | 0.08% | 156 |
|
|
2024
Q3 | $39.6M | Buy |
+37,651
| New | +$41.9M | 0.14% | 60 |
|
|
2023
Q4 | – | Sell |
-5,799
| Closed | -$4.77M | – | 2808 |
|
|
2023
Q3 | $4.77M | Sell |
5,799
-7,847
| -58% | -$6.17M | 0.05% | 508 |
|
|
2023
Q2 | $9.81M | Buy |
13,646
+10,574
| +344% | +$8.15M | 0.12% | 177 |
|
|
2023
Q1 | $2.52M | Sell |
3,072
-542
| -15% | -$409K | 0.04% | 663 |
|
|
2022
Q4 | $2.61M | Buy |
+3,614
| New | +$2.67M | 0.05% | 489 |
|
|
2022
Q3 | – | Sell |
-1,690
| Closed | -$999K | – | 2629 |
|
|
2022
Q2 | $999K | Buy |
+1,690
| New | +$1.1M | 0.03% | 885 |
|
|
2021
Q3 | – | Sell |
-1,591
| Closed | -$889K | – | 2741 |
|
|
2021
Q2 | $889K | Buy |
+1,591
| New | +$806K | 0.02% | 915 |
|
|
2020
Q2 | – | Sell |
-2,426
| Closed | -$1.19M | – | 1377 |
|
|
2020
Q1 | $1.19M | Sell |
2,426
-2,670
| -52% | -$1.1M | 0.11% | 202 |
|
|
2019
Q4 | $1.91M | Buy |
+5,096
| New | +$1.71M | 0.09% | 300 |
|
|
2019
Q3 | – | Sell |
-785
| Closed | -$246K | – | 1298 |
|
|
2019
Q2 | $246K | Sell |
785
-1,650
| -68% | -$549K | 0.01% | 909 |
|
|
2019
Q1 | $1M | Buy |
+2,435
| New | +$1M | 0.04% | 470 |
|
|
2018
Q4 | – | Sell |
-1,278
| Closed | -$516K | – | 1199 |
|
|
2018
Q3 | $516K | Sell |
1,278
-7,754
| -86% | -$2.95M | 0.01% | 676 |
|
|
2018
Q2 | $3.12M | Buy |
+9,032
| New | +$2.82M | 0.11% | 150 |
|
|
2018
Q1 | – | Sell |
-4,017
| Closed | -$1.51M | – | 1194 |
|
|
2017
Q4 | $1.51M | Buy |
+4,017
| New | +$1.63M | 0.04% | 239 |
|
|
2017
Q2 | – | Sell |
-600
| Closed | -$233K | – | 1317 |
|
|
2017
Q1 | $233K | Buy |
+600
| New | +$222K | 0.01% | 1152 |
|
|
2016
Q4 | – | Sell |
-4,608
| Closed | -$1.85M | – | 1567 |
|
|
2016
Q3 | $1.85M | Buy |
4,608
+1,652
| +56% | +$663K | 0.04% | 231 |
|
|
2016
Q2 | $1.03M | Buy |
+2,956
| New | +$1.14M | 0.02% | 439 |
|
|
2016
Q1 | – | Sell |
-700
| Closed | -$380K | – | 1936 |
|
|
2015
Q4 | $380K | Sell |
700
-390
| -36% | -$211K | 0.01% | 1088 |
|
|
2015
Q3 | $507K | Buy |
1,090
+690
| +173% | +$371K | 0.02% | 779 |
|
|
2015
Q2 | $204K | Buy |
+400
| New | +$195K | 0.01% | 1329 |
|
|
2014
Q4 | – | Sell |
-2,499
| Closed | -$901K | – | 1575 |
|
|
2014
Q3 | $901K | Buy |
+2,499
| New | +$838K | 0.03% | 343 |
|
|
2014
Q2 | – | Sell |
-893
| Closed | -$268K | – | 1289 |
|
|
2014
Q1 | $268K | Buy |
+893
| New | +$275K | 0.01% | 882 |
|
|
2013
Q3 | – | Sell |
-1,600
| Closed | -$360K | – | 932 |
|
|
2013
Q2 | $360K | Buy |
+1,600
| New | +$373K | 0.03% | 468 |
|
Other funds holding REGN
VCM
N
Tudor Investment Corp's REGN Position: Q3 2025 in Review
Tudor Investment Corp sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 84,550 shares — an estimated $47.8M sold.
Tudor Investment Corp first reported a position in REGN in Q2 2013 and held it in 26 quarters. The position peaked at $80M in Q1 2025. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.
- Tudor Investment Corp reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Tudor Investment Corp sold 84,550 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $47.8M.
- Tudor Investment Corp first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 26 quarters.
- Tudor Investment Corp's Regeneron Pharmaceuticals position peaked at $80M in Q1 2025.
- 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.
Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.